.

Flexible Flat-Rate Plans

Flat-rate pricing for predictable budgeting

Short-term plans for project- or client-based billing

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Abbvie Endocrine Inc Company Profile

« Back to Dashboard

Summary for Applicant: Abbvie Endocrine Inc

Patents:4
Tradenames:3
Ingredients:1
NDAs:6
Drug Master File Entries: (click here to view)16
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Abbvie Endocrine Inc
LUPRON DEPOT-PED
leuprolide acetate
INJECTABLE;INJECTION020263-005Jan 21, 1994RXYes6,036,976<disabled> <disabled>
Abbvie Endocrine Inc
LUPRON
leuprolide acetate
INJECTABLE;INJECTION019010-001Apr 9, 1985DISCNNo<disabled><disabled>
Abbvie Endocrine Inc
LUPRON DEPOT
leuprolide acetate
INJECTABLE;INJECTION020517-003Jun 17, 2011RXNo8,921,326<disabled>Y <disabled>
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

`abc